Fortis Malar Hospitals Ltd — Others, 04-07-2025: AGM/EGM

Fortis Malar Hospitals Limited has announced a board meeting on July 30, 2025, through Video Conferencing to consider adoption of its financial results for the quarter and half-year ended June 30, 2025, appointment of Dr. Ritu Garg as a Non-Executive Non-Independent Director, ratification of cost auditors' remuneration, and appointment of secretarial auditors for the next five years. Dr. Ritu Garg was appointed as an Additional Director in May 2025 and is being regularized. The company has no ongoing business operations following a slump sale transaction in February 2024 and is evaluating corporate restructuring options. It declared an interim dividend of ₹40 per share and a final dividend of ₹2.50 per share for FY24. The company has one wholly owned subsidiary, Malar Stars Medicare Limited, which has applied for conversion into a Section 8 company. Auditors have reported the standalone and consolidated financial statements with an unmodified opinion, confirming going concern status despite no business operations. Key financials for FY25 show consolidated total income of ₹2.72 Cr versus ₹65.96 Cr in FY24, and profit after tax of ₹0.39 Cr versus ₹45.32 Cr, reflecting impacts post business divestment. No material regulatory non-compliance or fraud has been reported. The shareholding structure remains stable with Promoter Fortis Hospitals Limited holding 62.71%. The company continues to maintain internal controls, and no employee remains on the payroll as business operations have ceased.